Ectonucleoside triphosphate diphosphohydrolases and ecto-5'-nucleotidase in purinergic signaling: how the field developed and where we are now.


Journal

Purinergic signalling
ISSN: 1573-9546
Titre abrégé: Purinergic Signal
Pays: Netherlands
ID NLM: 101250499

Informations de publication

Date de publication:
03 2021
Historique:
received: 01 09 2020
accepted: 12 11 2020
pubmed: 19 12 2020
medline: 15 12 2021
entrez: 18 12 2020
Statut: ppublish

Résumé

Geoffrey Burnstock will be remembered as the scientist who set up an entirely new field of intercellular communication, signaling via nucleotides. The signaling cascades involved in purinergic signaling include intracellular storage of nucleotides, nucleotide release, extracellular hydrolysis, and the effect of the released compounds or their hydrolysis products on target tissues via specific receptor systems. In this context ectonucleotidases play several roles. They inactivate released and physiologically active nucleotides, produce physiologically active hydrolysis products, and facilitate nucleoside recycling. This review briefly highlights the development of our knowledge of two types of enzymes involved in extracellular nucleotide hydrolysis and thus purinergic signaling, the ectonucleoside triphosphate diphosphohydrolases, and ecto-5'-nucleotidase.

Identifiants

pubmed: 33336318
doi: 10.1007/s11302-020-09755-6
pii: 10.1007/s11302-020-09755-6
pmc: PMC7954995
doi:

Substances chimiques

Receptors, Purinergic 0
5'-Nucleotidase EC 3.1.3.5
Adenosine Triphosphatases EC 3.6.1.-
Adenosine K72T3FS567

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

117-125

Références

Purinergic Signal. 2011 Mar;7(1):21-45
pubmed: 21484095
Biochem Pharmacol. 2015 Jan 15;93(2):171-81
pubmed: 25449596
Semin Thromb Hemost. 2005 Apr;31(2):234-46
pubmed: 15852226
Structure. 2012 Dec 5;20(12):2161-73
pubmed: 23142347
Purinergic Signal. 2006 Jun;2(2):351-60
pubmed: 18404475
Trends Immunol. 2016 Jul;37(7):427-439
pubmed: 27236363
Int Rev Cytol. 1995;158:141-214
pubmed: 7721538
Nat Med. 1999 Sep;5(9):1010-7
pubmed: 10470077
J Clin Invest. 1997 Mar 15;99(6):1351-60
pubmed: 9077545
Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1981-9
pubmed: 20852039
Immunol Rev. 1998 Feb;161:95-109
pubmed: 9553767
J Clin Invest. 2004 May;113(10):1440-6
pubmed: 15146241
Purinergic Signal. 2007 Mar;3(1-2):171-80
pubmed: 18404431
F1000Res. 2014 Jul 21;3:163
pubmed: 25717362
Purinergic Signal. 2018 Jun;14(2):109-120
pubmed: 29332180
Neuropharmacology. 1997 Sep;36(9):1189-200
pubmed: 9364474
J Mol Biol. 2012 Jan 13;415(2):288-306
pubmed: 22100451
Am J Physiol Cell Physiol. 2019 Dec 1;317(6):C1079-C1092
pubmed: 31461341
Purinergic Signal. 2012 Sep;8(3):437-502
pubmed: 22555564
Structure. 2010 Feb 10;18(2):228-38
pubmed: 20159467
J Biol Chem. 1990 Feb 5;265(4):2178-83
pubmed: 2298743
Immunotherapy. 2019 Aug;11(11):983-997
pubmed: 31223045
J Biol Chem. 2003 Nov 21;278(47):46195-8
pubmed: 12947102
Adv Clin Chem. 1968;11:277-328
pubmed: 4885757
J Mol Biol. 2001 May 25;309(1):255-66
pubmed: 11491294
J Struct Biol. 2014 Mar;185(3):336-41
pubmed: 24462745
Biochem Biophys Res Commun. 1996 Jan 26;218(3):916-23
pubmed: 8579614
Neurochem Int. 2008 Mar-Apr;52(4-5):634-48
pubmed: 18029057
MAbs. 2016;8(3):454-67
pubmed: 26854859
Adv Pharmacol. 2011;61:301-32
pubmed: 21586363
Med Res Rev. 2014 Jul;34(4):703-43
pubmed: 24115166
Purinergic Signal. 2006 Jun;2(2):409-30
pubmed: 18404480
Med Chem. 2020;16(5):689-702
pubmed: 31203806
Semin Cell Dev Biol. 2011 Apr;22(2):194-204
pubmed: 21320621
J Mol Cell Cardiol. 2011 Dec;51(6):927-35
pubmed: 21939667
Purinergic Signal. 2013 Jun;9(2):175-82
pubmed: 23274765
Chembiochem. 2012 Nov 5;13(16):2384-91
pubmed: 22997138
J Med Chem. 2019 Apr 11;62(7):3677-3695
pubmed: 30895781
Crit Rev Biochem Mol Biol. 2014 Nov-Dec;49(6):473-97
pubmed: 25418535
J Immunol. 1994 Oct 15;153(8):3574-83
pubmed: 7930580
Biochim Biophys Acta. 1974 Apr 29;345(2):180-97
pubmed: 4366461
Cell Rep. 2019 May 21;27(8):2411-2425.e9
pubmed: 31116985
Biofactors. 2007;31(2):77-98
pubmed: 18806312
Semin Thromb Hemost. 2005 Apr;31(2):217-33
pubmed: 15852225
J Biol Chem. 1996 Apr 26;271(17):9898-901
pubmed: 8626624
Nat Rev Cancer. 2018 Oct;18(10):601-618
pubmed: 30006588
J Biomed Biotechnol. 2012;2012:208204
pubmed: 23125523
J Med Chem. 2020 Mar 26;63(6):2941-2957
pubmed: 32045236
Eur J Biochem. 1991 Dec 18;202(3):855-61
pubmed: 1765099
Prog Biophys Mol Biol. 1988;52(1):1-37
pubmed: 2978278
Nat Rev Drug Discov. 2013 Apr;12(4):265-86
pubmed: 23535933
J Exp Med. 2004 Dec 6;200(11):1395-405
pubmed: 15583013
Oncoimmunology. 2016 Jul 11;5(8):e1208875
pubmed: 27622077
Eur J Biochem. 1990 Aug 17;191(3):563-9
pubmed: 2129526
Naunyn Schmiedebergs Arch Pharmacol. 2000 Nov;362(4-5):299-309
pubmed: 11111825
J Cell Physiol. 2021 Feb;236(2):851-862
pubmed: 32648591
Mini Rev Med Chem. 2015;15(1):21-33
pubmed: 25694081
Front Immunol. 2019 Mar 19;10:507
pubmed: 30941139
Purinergic Signal. 2006 Jun;2(2):379-89
pubmed: 17710224
Dig Dis. 2014;32(5):516-24
pubmed: 25034284
Structure. 2013 Aug 6;21(8):1460-75
pubmed: 23830739
Ann Clin Lab Sci. 1990 Mar-Apr;20(2):123-39
pubmed: 2183704
Prog Brain Res. 1999;120:371-85
pubmed: 10551012
Dokl Akad Nauk SSSR. 1955 May 1;102(1):133-6
pubmed: 13241330
Prog Neurobiol. 1996 Aug;49(6):589-618
pubmed: 8912394
Folia Haematol Int Mag Klin Morphol Blutforsch. 1959;76:422-31
pubmed: 13843980
J Mol Med (Berl). 2017 Sep;95(9):915-925
pubmed: 28547076
Purinergic Signal. 2006 Jun;2(2):343-50
pubmed: 18404474
J Biol Chem. 1974 Nov 25;249(22):7111-20
pubmed: 4373458
Science. 1974 Mar 15;183(4129):1096-8
pubmed: 4204581
Circ Res. 2004 Oct 15;95(8):814-21
pubmed: 15358667
Biochemistry. 1999 Jan 5;38(1):321-8
pubmed: 9890913
Eur J Biochem. 1999 May;262(1):102-7
pubmed: 10231370
Eur J Biochem. 1995 Nov 15;234(1):66-74
pubmed: 8529670
J Biol Chem. 1996 Dec 20;271(51):33116-22
pubmed: 8955160
Pharmacol Rev. 1972 Sep;24(3):509-81
pubmed: 4404211
Adv Pharmacol. 2011;61:263-99
pubmed: 21586362
Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):14789-94
pubmed: 23959882
Nat Rev Nephrol. 2020 Sep;16(9):509-524
pubmed: 32641760
J Biomed Biotechnol. 2012;2012:473712
pubmed: 23133312
J Mol Cell Cardiol. 2012 May;52(5):958-61
pubmed: 22269791
Proc Natl Acad Sci U S A. 2008 May 13;105(19):6882-7
pubmed: 18458329
J Med Chem. 2020 Nov 25;63(22):13444-13465
pubmed: 32786396
Curr Med Chem. 2015 Apr 08;22(15):1776 - 1792
pubmed: 25850771
Am J Physiol Cell Physiol. 2011 Aug;301(2):C530-9
pubmed: 21593451
Biochem J. 1992 Jul 15;285 ( Pt 2):345-65
pubmed: 1637327
Biochem J. 1945;39(5):451-8
pubmed: 16747937
Genomics. 1998 Jun 15;50(3):357-67
pubmed: 9676430
Immunol Rev. 2017 Mar;276(1):121-144
pubmed: 28258700
Mol Cell Biochem. 1981 Jul 7;37(2):91-9
pubmed: 6116173

Auteurs

Herbert Zimmermann (H)

Goethe University, Institute of Cell Biology and Neuroscience, Max-von-Laue-Str. 13, 60438, Frankfurt am Main, Germany. h.zimmermann@bio.uni-frankfurt.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH